Latest news, reports, and more from the RedChip Nation.
Discovering Tomorrow's Blue Chips Today
January 22, 2020     Contact    
Can-Fite (NYSE American: CANF) and Univo Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects


Can-Fite BioPharma (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to the A3 adenosine receptor (A3AR), addressing cancer, liver and inflammatory diseases, announced new findings in its collaboration with Univo Pharmaceuticals (TASE:UNVO) characterizing the effects of cannabinoids on diseases mediated through the A3 adenosine receptor (A3AR).


Why It Matters: Joint research shows that certain cannabinoid-based formulations exert a highly potent beneficial effect on diseased cells by binding to A3AR, and these findings present new opportunities for the development of cannabinoids in the treatment of a variety of diseases in which there is an overexpression of A3AR. Can-Fite filed a patent application titled "Cannabinoids for use in treating A3 adenosine receptor-associated conditions" based on these findings and covering all the clinical indications in which A3AR is overexpressed.


Key Quote: “As the medical community is now recognizing the opportunities within this exciting area, it is important that we protect our innovative approach and the investments that we made along the way. In addition to our small molecule drugs, Piclidenoson and Namodenoson, which are currently in Can-Fite’s advanced stage clinical pipeline, we now have the opportunity to develop a whole new class of cannabinoid-A3AR drugs in partnership with Univo.” – Dr. Pnina Fishman, CEO


The Backstory: Can-Fite, a global leader in discovering and developing drugs which target A3AR, is collaborating with Univo Pharmaceuticals and utilizes its platform technology within the framework of this collaboration to develop cannabinoids for the treatment of large unmet medical needs. Can-Fite announced a strategic partnership with Univo Pharmaceuticals, a medical cannabis company, in September 2019, and Univo’s CEO Golan Bitton joined Can-Fite’s Board of Directors in December 2019.



Can-Fite Biopharma (CANF) is a client of RedChip Companies, Inc. CANF agreed to pay RedChip Companies, Inc. a cash fee of $5,000 monthly, beginning in August 2019, and 16,500 shares of CANF Rule 144 stock for 6 months of RedChip investor awareness services and consulting services.

Esports Entertainment Group (OTCQB: GMBL) Releases Upgraded VIE.GG Esports Gambling Platform


Esports Entertainment Group (OTCQB: GMBL), a licensed online gambling company with a focus on esports wagering and 18+ gaming, announced the release of the latest version of (, the Company's esports wagering platform.


Why It Matters: This latest upgrade delivers notable new features, including additional betting options such as Fixed Odds, Pari-mutuel, Fantasy and Pool Betting, complementing the company’s main P2P option. The upgrade also delivers significant content enhancements, including real-time streaming and event coverage, as well as full compatibility with all major desktop, mobile and tablet devices and their respective operating systems.


Key Quote: “This is another major milestone for our Company. This is our strongest release ever, with every new feature esports gambling enthusiasts could wish for in a platform. Combined with our unsurpassed transparency as a result of our status as a fully reporting public company, we believe is strongly positioned for success in 2020.” – Grant Johnson, CEO


The Backstory: Esports Entertainment Group, Inc. is a licensed online gambling company with a focus on esports wagering and 18+ gaming. Esports Entertainment offers bet exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta and Warsaw, Poland.



Esports Entertainment Group, Inc. (GMBL) is a client of RedChip Companies, Inc. GMBL agreed to pay RedChip Companies, Inc. a $4,000 monthly cash fee, beginning in June 2018, and 225,000 shares of Rule 144 stock for RedChip investor awareness services.

Quote of the Week
"Look at what you can afford to lose, it’s a numbers game."
- Buzz Heidkte, Owner MidSouth Investor Fund
Lesson of the Week
Understand everything you can about a company and you’ll increase the odds of your success.
Read More
Latest Videos
This Week on RedChip TV: 3 Attractive Small-Cap Stocks for Your Portfolio
Watch RedChip’s exclusive interviews with executives from three exciting small-cap companies: Medalist Diversified REIT (NASDAQ: MDRR), Can-Fite BioPharma (NYSE American: CANF), and Boxlight (NASDAQ: BOXL).
Watch Now
Medalist Diversified REIT: Quarterly Dividends with $4.75 Price Target from Aegis
Medalist Diversified REIT (NASDAQ: MDRR) is a public Virginia-based Real Estate Investment Trust specializing in acquiring, owning and managing value-add commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns.
Watch Now
Red Cat CEO Interview: Blockchain-Based Storage and Analytics for Drone Industry
Red Cat Holdings (OTC: RCAT) is a leading provider of secure blockchain-based distributed storage, analytics and SaaS solutions for commercial and consumer customers in the drone industry. Through its innovative products and leadership, Red Cat provides solutions for regulators to track and review flight data, insurance companies to insure drones, and pilots to become compliant with regulations.
Watch Now
MySize CEO Interview: Game-Changing Technology Addressing Multiple Large Market Opportunities
My Size (TASE: MYSZ) (NASDAQ: MYSZ) has developed a unique measurement technology based on sophisticated algorithms and cutting-edge technology with broad applications including the apparel, e-commerce, DIY, shipping and parcel delivery industries.
Watch Now
Digital Ally: Expanding Sales of Body-Cam Technology in Multiple Markets
Digital Ally (NASDAQ: DGLY) pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security, with a complete product solution suite including in-car and body cameras, cloud and local management software, and automatic recording technology.
Watch Now
Can-Fite CEO Interview: Multiple Phase III Clinical Trial Programs
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases including advanced liver cancer and NASH.
Watch Now
Immuron's New Antibiotic Alternative Generating Strong Sales Growth
Immuron Ltd. (NASDAQ: IMRN; ASX: IMC), is an Australian biopharmaceutical company focused on developing and commercializing orally delivered polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.
Watch Now
Interview with Leading Tech Developer for Maritime Industry
eMARINE Global (OTC: EMRN) is a leading provider of information and communications technology (ICT) solutions for the global maritime industry.
Watch Now
Preferred Shares Pay Quarterly Distributions at 12% Per Annum Rate
1847 Holdings (OTC: EFSH) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly-traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries.
Watch Now
Genetic Technologies: New Risk Assessment Tests for Cancer
Exclusive interview with Dr. Jerzy Mechnicki , interim-CEO of Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class.
Watch Now
Order Small Stocks, Big Money Today!
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
MidSouth Week in Review
The budget deficit hit $1.02 trillion in 2019, a 17% increase from 2018, marking the first deficit exceeding $1 trillion since 2012.
Read More
Weekly Index Performance
Small-cap stocks led the market higher last week, fueled by the signing of a China trade deal.
Read More
About RedChip
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
RedChip Disclosure
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at and view RedChip’s Disclosures.
Copyright © 2020 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.